INT6596
From wiki-pain
(Difference between revisions)
Latest revision as of 12:32, 23 September 2012
Context
|
Info
|
Confidence
|
0.61
|
First Reported
|
1989
|
Last Reported
|
2010
|
Negated
|
1
|
Speculated
|
0
|
Reported most in
|
Body
|
Documents
|
33
|
Total Number
|
35
|
Disease Relevance
|
27.01
|
Pain Relevance
|
7.26
|
|
|
|
[edit] Sentences Mentioned In
Key:
|
Protein
|
Mutation
|
Event
|
Anatomy
|
Negation
|
Speculation
|
Pain term
|
Disease term
|
However, when the patients were compared by subgroups, with and without CC, the frequency of HLA-DRB1*11 was significantly increased in the Kawasaki disease patients with CC (p < 0.04; RR = 4.7), and HLA-DRB1*04 was increased in the Kawasaki disease patients without CC (p < 0.05; RR =1.9) compared with the healthy control group.
|
|
|
The frequency of the HLA DRB1*12 allele was found to be decreased in patients with migraine while the DRB1*16 allele, coding for HLA DR2 antigen, was significantly increased in comparison with controls.
|
|
|
To conclude, patients with VKH had a higher incidence of HLA-DRB1 *0405, indicating that the HLA-DRB1 *0405 allele might play a role in the pathogenesis of VKH disease.
|
|
|
The HLA-DRB1 promoter was resequenced in 322 HLA-DRB1*15 homozygous individuals, both MS affected and unaffected.
|
|
|
Further, extension of the analysis from HLA-A to HLA-DRB1 increases the size of allele-defined CEHs up to 2.6 Mb.
|
|
5)
|
Confidence
|
0.48
|
Published
|
2007
|
Journal
|
BMC Genet
|
Section
|
Body
|
Doc Link
|
PMC1853106
|
Disease Relevance
|
0
|
Pain Relevance
|
0
|
|
Regarding DR locus, the frequency of HLA-DRB1*15 and DRB1*04 has been increased in CDMS patients, whilst the frequency of HLA-DRB1*07 and *11 was much higher in ON patients.
|
|
6)
|
Confidence
|
0.47
|
Published
|
2005
|
Journal
|
Eur. J. Neurol.
|
Section
|
Abstract
|
Doc Link
|
15613143
|
Disease Relevance
|
1.17
|
Pain Relevance
|
0.98
|
|
Kim and associates found that HLA-DRB1 *0405 was greatly increased in patients with VKH syndrome among Koreans and might have an important role in the development of the clinical course of VKH [11].
|
|
|
Flow cytometric analysis showed a specific increase in the cell surface expression of HLA-DRB1 upon addition of vitamin D only in HLA-DRB1*15 bearing lymphoblastoid cells.
|
|
8)
|
Confidence
|
0.43
|
Published
|
2009
|
Journal
|
PLoS Genetics
|
Section
|
Abstract
|
Doc Link
|
PMC2627899
|
Disease Relevance
|
0.73
|
Pain Relevance
|
0.16
|
|
The HLA-DRB1 promoter was resequenced in 322 HLA-DRB1*15 homozygous individuals, both MS affected and unaffected.
|
|
|
Regarding DR locus, the frequency of HLA-DRB1*15 and DRB1*04 has been increased in CDMS patients, whilst the frequency of HLA-DRB1*07 and *11 was much higher in ON patients.
|
|
10)
|
Confidence
|
0.41
|
Published
|
2005
|
Journal
|
Eur. J. Neurol.
|
Section
|
Abstract
|
Doc Link
|
15613143
|
Disease Relevance
|
1.18
|
Pain Relevance
|
0.99
|
|
Among the HLA-DRB1 alleles, there was no increase in the frequency of alleles in the Kawasaki disease patients compared with the healthy control group.
|
|
|
The myeloid dendritic cells in CSF expressed higher levels of HLA-DR, CD86, CD80 and CD40 than those in blood, whereas expression of these molecules by plasmacytoid dendritic cells was equal in blood and CSF.
|
|
12)
|
Confidence
|
0.34
|
Published
|
2001
|
Journal
|
Brain
|
Section
|
Abstract
|
Doc Link
|
11222448
|
Disease Relevance
|
1.00
|
Pain Relevance
|
0.43
|
|
Among HLA-DRB1 alleles, a significant increase in DRB1*11 was found in comparison with controls (P = 0.01, OR = 2.2, 1.2 < CI < 4.5).
|
|
13)
|
Confidence
|
0.33
|
Published
|
2010
|
Journal
|
Rheumatol. Int.
|
Section
|
Abstract
|
Doc Link
|
19655145
|
Disease Relevance
|
0.66
|
Pain Relevance
|
0.60
|
|
The increase of HLA-DR12 and HLA-DR1 in AU may be caused by linkage disequilibrium with B*2704 and B*2705, respectively.
|
|
|
The increase of HLA-DR12 and HLA-DR1 in AU may be caused by linkage disequilibrium with B*2704 and B*2705, respectively.
|
|
|
Among HLA-DRB1 alleles, a significant increase in DRB1*11 was found in comparison with controls (P = 0.01, OR = 2.2, 1.2 < CI < 4.5).
|
|
16)
|
Confidence
|
0.29
|
Published
|
2010
|
Journal
|
Rheumatol. Int.
|
Section
|
Abstract
|
Doc Link
|
19655145
|
Disease Relevance
|
0.67
|
Pain Relevance
|
0.60
|
|
In HLA-B27-associated AU, DRB1*0101 and DQB1*0501 were increased compared with HLA-B27-positive control subjects.
|
|
|
Cell surface marker analysis of blast cells disclosed that they were positive for anti-HLA-DR, CD19, CD24, CD33 and CD38, but were negative for CD10 and CD20.
|
|
18)
|
Confidence
|
0.13
|
Published
|
1989
|
Journal
|
Rinsho Ketsueki
|
Section
|
Abstract
|
Doc Link
|
2554012
|
Disease Relevance
|
0.58
|
Pain Relevance
|
0.12
|
|
The bottoms of these stromal bundles are adjacent (see border lines, panel B) and their migration appears to be influenced by HLA-DR+ (activated [67]) tissue macrophages (purple color, black and white arrows, panel C).
|
|
|
In addition to its effects on airway neutrophilia, we have recently reported that O3 challenge (0.4 ppm, 2 hr) causes an increase in expression of cell-surface phenotypes CD11b, mCD14, CD16, CD86, and HLA-DR on sputum monocytes recovered from normal volunteers (Alexis et al. 2004a).
|
|
|
This test has worked.